In the latest episode of The #HealthEquity podcast, our CEO, @jayiyer.bsky.social, speaks with James Reid, @helmsleytrust.bsky.social, about barriers to expanding access to #T1D care & how better alignment, integration & collaboration can help scale impact. Listen here➡️ tinyurl.com/yc633cyj

✍️ For The Guardian, Julia Kollewe reports on #AMRB26 findings, highlighting a 35% drop in antimicrobial R&D & uneven industry engagement. With #DrugResistance rising, can #innovation keep up? Read more➡️ https://tinyurl.com/nhcfx7uj#AMRB26#DrugResistance#innovation#AMR #pharma #HealthEquity #GlobalHealth

Are you a keen writer & editor who thrives on crafting crisp, clear prose? Join our team & work closely with our policy experts & researchers to help shape & structure findings & insights into digestible texts➡️ accesstomedicinefoundation.org/writer-editor #hiring #HiringAlert #NGOJobs

The antimicrobial pipeline is shrinking. #AMRB26 finds a 35% decline in pipeline projects from large research-based companies since 2021, underscoring the urgency of sustaining #innovation while ensuring new treatments reach patients most in need. Read more➡️ tinyurl.com/susrpke

Access to anti-infectives depends on affordability & availability in practice, not supply alone. #AMRB26 shows access barriers are shaped by local contexts & require tailored strategies, yet only 44% of products are covered by such strategies. Read more➡️ tinyurl.com/4nnzk6ry

#WorldTBDay is a reminder that #TB remains one of the deadliest infectious diseases. Yet tools to treat drug-resistant forms risk falling behind. #AMRB26 shows a 35% decline in antimicrobial R&D by #pharma, raising concerns for diseases like TB. Read more➡️ tinyurl.com/4nnzk6ry

How is the #pharma industry performing in the fight against #AMR? #AMRB26 presents a mixed picture. While some companies are making progress in specific areas, overall industry performance has declined since 2021 & progress remains uneven. Learn more👉 accesstomedicinefoundation.org/insights-res...

Over 80% of deaths linked to #AMR occur in #LMICs, where access to effective #antibiotics & #healthcare is often limited. Understanding what drives #AntimicrobialResistance & how to curb its spread is key to protecting modern medicine. Learn more👉 amrbenchmark2026.accesstomedicinefoundation.org

Discussions at yesterday’s #AMRB26 launch in London highlighted the fragility of the #AMR landscape. Participants emphasised that stronger partnerships, coordinated incentives & responsible use of #antibiotics will be key to sustaining progress. 🔗 accesstomedicinefoundation.org/news/tools-t...

NOW ONLINE: The 2026 AMR Benchmark #AMRB26 finds pockets of progress in how #pharma companies are tackling #AMR but #DrugResistance continues to outpace industry-wide efforts, underscoring the urgent need for more comprehensive action. Read the report👉 accesstomedicinefoundation.org/news/tools-t...

COMING SOON: How is the #pharma industry responding to the growing threat of #AMR? The 2026 AMR Benchmark #AMRB26, coming out tomorrow, assesses how 25 companies are addressing AMR, highlighting progress & remaining gaps. Read the methodology➡️ accesstomedicinefoundation.org/news/new-met...

Since 2017, the Foundation has tracked how #pharma companies address #AntimicrobialResistance across four Benchmark editions & research reports, analysing action in R&D, responsible manufacturing & access & stewardship. Explore our research on #AMR👉 tinyurl.com/yc8688u6

To mark the launch of the 2026 #AMR Benchmark, we're co-hosting a high-level forum with the Fleming Initiative on 10 March to revisit 2024 UN AMR commitments & explore how the Benchmark can drive stronger partnerships & faster industry action. Learn more👉 tinyurl.com/4y7uj83p

Since 2017, the Foundation has tracked how industry responds to #AMR & where stronger action is needed. Through the AMR Benchmark & thematic reports, we provide data & analyses to inform #GlobalHealth decision-making. Learn more👉 accesstomedicinefoundation.org/cross-sector...

#AMR is one of the most urgent threats to #GlobalHealth. Without decisive action, the medicines we rely on risk becoming ineffective, putting growing pressure on #HealthSystems. Tackling AMR requires sustained, cross-sector action. Learn more👉 accesstomedicinefoundation.org/cross-sector...

In her latest op-ed for @weforum.org, our CEO, @jayiyer.bsky.social, explores how #AI could help bridge #healthcare gaps worldwide & what must happen to ensure it benefits everyone, not just the well-resourced. Read more➡️ accesstomedicinefoundation.org/in-the-media... #Access2Meds #HealthEquity

This week, our CEO @jayiyer.bsky.social is attending the #AMR 2026 Summit in Sydney, where she'll join a panel on investor action & AMR & take part in a keynote session on how environmental requirements affect smaller antibiotic manufacturers. Learn more➡️ tinyurl.com/38rdtw7a #Access2Meds

Are you a keen writer & editor who thrives on crafting crisp, clear prose? Join our team & work closely with our policy experts & researchers to help shape & structure findings & insights into digestible texts➡️ accesstomedicinefoundation.org/writer-editor #hiring #HiringAlert #NGOJobs

#HiringNow 📣 We’re looking for a Researcher to support analytical work across our programmes, assessing how #healthcare companies address #Access2Meds & turning data into insights that inform our work. Learn more & apply now➡️ accesstomedicinefoundation.org/researcher #hiring #vacancy #research

In recognition of #WorldCancerDay, we’re looking back at an episode of The #HealthEquity Podcast featuring Dr Fatima Cardoso of ABC Global Alliance, in conversation w/ our CEO @jayiyer.bsky.social on advancing equity in #CancerCare for women in #LMICs. Listen here➡️ tinyurl.com/29v6fhb9 #cancer

#NTDs affect 1B+ people worldwide, mostly in underserved communities. Gaps in #Access2Meds mean many are still left behind. #WorldNTDDay is a moment to reflect on what’s needed to close these gaps, including stronger action from the industry. Learn more➡️ tinyurl.com/4r4kf4s9 #BeatNTDs #GlobalHealth

Antimalarial resistance is rising, & children in Africa are at greatest risk. With treatments losing effectiveness & funding under pressure, decades of progress are under threat. Our latest industry trend analysis shows how companies can take meaningful action➡️ tinyurl.com/39r624jw

This week, our CEO @jayiyer.bsky.social is attending #JPMHC26 in San Francisco, joining #pharma leaders, #investors & policymakers to discuss strategic priorities & investment trends shaping #healthcare worldwide. Learn more➡️ accesstomedicinefoundation.org/event/jayasr... #Access2Meds #GlobalHealth

Millions still lack access to essential medicines, a gap demanding urgent action. Our CEO, @jayiyer.bsky.social, explains why inclusive #ClinicalResearch is key to turning #innovation into access. Join us in driving systemic change. Watch #HealthHeroes➡️ accesstomedicinefoundation.org/news/how-the...

📣Are you a #finance professional who wants their work to contribute to real change in #GlobalHealth? We’re #hiring a Financial Controller to take full ownership of our day-to-day financial operations. Interested? Learn more & apply➡️ accesstomedicinefoundation.org/financial-co... #vacancy #HiringNow

Innovation only matters when it reaches everyone. For millions in #LMICs, lifesaving products are still out of reach. This inequity is the greatest health challenge of our time. Join us in driving systemic change. Invest in access. 🔗 accesstomedicinefoundation.org/news/how-the... #HealthHeroes

Clinical research remains concentrated in only a few places, limiting access to new treatments. #ATMI24 shows that only 43% of #ClinicalTrials took place in any #LMICs, despite these countries being home to nearly 80% of the global population. Read more➡️ tinyurl.com/mry2kb8p #Access2Meds

Most clinical research takes place far from the communities most affected by disease. Linda-Gail Bekker, CEO at DTHF, shares how locally-led #HIV & #TB trials in South Africa have strengthened access. The same resolve is needed for #NCDs. Learn more➡️ accesstomedicinefoundation.org/healthcare-i...

Investors can drive progress in #GlobalHealth. Timothy Hay, Analyst & Portfolio Manager at Stewart Investors, shares how the Foundation’s insights help guide investor engagement with #pharma companies, turning evidence into impact. Learn more about our work with #investors➡️ tinyurl.com/4xxsbmw3 #ESG

Watch Anathi Nqothole, a #PrEP user from South Africa, who shares how access to the right care helped her thrive. Africa carries a quarter of the global disease burden but hosted just 1.1% of #ClinicalTrials in 2023 - expanding clinical research is vital. Read more➡️ tinyurl.com/3h6bh8sa

Innovation in medicine is accelerating, yet essential medicines remain out of reach in #LMICs. We've shown progress in guiding companies to expand access. Advance our impact by supporting our evidence-based research. Invest in access. Watch #HealthHeroes➡️ tinyurl.com/5n6vcfkd

Working together is essential to creating global #HealthEquity. Coming tomorrow, the #HealthHeroes documentary highlights our impact on the ground & how joint action can drive lasting change. Learn more about our work➡️ accesstomedicinefoundation.org/achievements... #Access2Meds #GlobalHealth

With #GlobalHealth threats on the rise, the need to bridge access gaps is more urgent than ever. For over 20 years, the Foundation has guided #healthcare companies so that lifesaving products reach the people who need them most. Learn more➡️ accesstomedicinefoundation.org/healthcare-i... #Access2Meds

Access to basic #medicines & essential #healthcare products is still lagging for 80% of the world’s population. In #LMICs, lifesaving products are often out of reach, & preventable deaths are all too common. What does this gap mean in real terms?➡️ accesstomedicinefoundation.org/healthcare-i...

In an interview for @devex.com, our CEO @jayiyer.bsky.social discusses what the arrival of #semaglutide generics could mean for people living with #diabetes in #LMICs. What will it take to turn patent expiry into a real opportunity for patients in these countries? Read more➡️ tinyurl.com/3jh9jwrj

Tomorrow, in partnership with @who.int, we’re hosting a live #webinar in recognition of #WAAW 2025 on how #investors can strengthen the global response to #AMR & drive company accountability. Register here➡️ tinyurl.com/ycj9j6xc #ESG #ESGInvesting

On #WorldDiabetesDay, we spotlight the vital role #pharma companies can play in expanding access to #insulin & essential care. Their commitment can lift the burden of #diabetes for people in #LMICs. Learn how we work to enhance access to #DiabetesCare➡ accesstomedicinefoundation.org/cross-sector...

In a new @devex.com op-ed, our CEO @jayiyer.bsky.social writes about how smart policies can strengthen Africa’s health financing & outlines five strategies that can help shift the continent from crisis mode to long-term financial resilience. Read more➡️ accesstomedicinefoundation.org/in-the-media...

How can investors strengthen the global response to #AMR? In partnership with @who.int, we're hosting a live #webinar during #WAAW 2025 to explore how #investors can help drive company accountability & reinforce global commitments. Learn more & register➡️ tinyurl.com/ycj9j6xc #ESG #DrugResistance

What will it take to achieve #VaccineEquity? In the latest episode of The #HealthEquity podcast, @jayiyer.bsky.social speaks with Dr Jerome Kim, Director General of the International Vaccine Institute (IVI), about building #vaccine security & ensuring access for all. Listen here➡️ bit.ly/45gcjjL

This week, our Research Coordinator, Emma Shiffman, is attending #ISPAD2025, where she'll present findings from our report on access to #diabetes care for children & young people, & the role of #pharma in expanding access in #LMICs. Learn more➡️ accesstomedicinefoundation.org/event/founda...

How can investors strengthen the global response to #AMR? In partnership with @who.int, we're hosting a live #webinar during #WAAW 2025 to explore how #investors can help drive company accountability & reinforce global commitments. Learn more & register➡️ tinyurl.com/ycj9j6xc #ESG #DrugResistance

How can investors strengthen the global response to #AMR? In partnership with @who.int, we're hosting a live #webinar during #WAAW 2025 to explore how #investors can help drive company accountability & reinforce global commitments. Learn more & register➡️ tinyurl.com/ycj9j6xc #ESG #DrugResistance

📣 Join our team in Amsterdam! We're looking for a Company Engagement Officer to manage relationships with #healthcare companies & engage industry stakeholders to drive change in #Access2Meds in #LMICs. Interested? Apply here➡️ accesstomedicinefoundation.org/company-enga... #vacancy #hiring #NGOJobs

In September, together with PGIM Fixed Income & Jennison Associates, we hosted a high-level roundtable alongside #UNGA80 to discuss how companies define, measure & report on patient reach. The key insights & takeaways are captured in a meeting report, now available here➡️ tinyurl.com/5n6fyfsf

On 11 Nov, the WHO’s GAP-f is hosting a #webinar in collaboration with the Access to Medicine Foundation to discuss how the #pharma industry can accelerate the development, delivery & access to critical paediatric medicines. Register here➡️ accesstomedicinefoundation.org/event/who-to...

Today, our CEO @jayiyer.bsky.social is taking the stage at #WHS2025 in Berlin, where she'll discuss how automation & #AI can strengthen #HealthSystems & how #pharma must ensure that #LMICs are prioritised as these technologies evolve. Learn more➡️ tinyurl.com/2hfxj4x7 @worldhealthsummit.bsky.social

For PharmaBoardroom, our CEO, @jayiyer.bsky.social, writes about what it will take to shape the next century of #diabetes care, calling for systemic collaboration between industry, governments & investors to ensure no one is left behind. Read more➡️ accesstomedicinefoundation.org/in-the-media...

NOW ONLINE: Methodology for the 2026 Access to Medicine Index #ATMI26 As #GlobalHealth funding tightens, company action on innovation, delivery & affordability is crucial. The 2026 Index Methodology zeroes in on scalable actions for lasting impact➡️ accesstomedicinefoundation.org/news/2026-in...

The Foundation welcomes Ethiopia’s recognition as an ML3 regulatory system – a milestone for access to quality, safe & effective medical products. Our recent review explores what ML3 means for expanding clinical trial research & company engagement across Africa➡️ tinyurl.com/3h6bh8sa